Dr. Sudha Nahar, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 17 Clyde Rd, Suite 101, Somerset, NJ 08873 Phone: 732-873-1600 Fax: 732-873-1606 |
Scott L Aronson, MD Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 33 Clyde Rd, Ste 102, Somerset, NJ 08873 Phone: 732-873-9200 Fax: 732-873-1699 |
Dr. Lawrence M Pickover, MD Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 81 Veronica Ave, Suite 206, Somerset, NJ 08873 Phone: 732-846-2777 Fax: 732-828-1950 |
Dr. Ira Merkel, Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 33 Clyde Rd, Suite 102, Somerset, NJ 08873 Phone: 732-873-9200 Fax: 732-873-1699 |
Ritu Nahar, MD Internal Medicine - Gastroenterology Medicare: Medicare Enrolled Practice Location: 17 Clyde Rd Ste 101, Somerset, NJ 08873 Phone: 732-873-1600 Fax: 732-548-7408 |
Dr. Syed Qaiser Shamim, MD Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1283 State Route 27, Somerset, NJ 08873 Phone: 732-745-9025 Fax: 732-545-3423 |
Dr. William James Ferges, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 33 Clyde Rd, Suite 102, Somerset, NJ 08873 Phone: 732-873-9200 Fax: 732-873-1699 |
Dr. Anna Platovsky, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 33 Clyde Rd Ste 102, Somerset, NJ 08873 Phone: 732-873-9200 |
News Archive
University of Utah Department of Medicine researchers have received $16 million from the National Institutes of Health (NIH) to set up a translational research center to study the cellular and molecular causes of blood clots, a serious threat to millions of people who have diabetes, are obese or have other metabolic disorders.
Kitov Pharmaceuticals, an innovative biopharmaceutical company focused on late-stage drug development, announced today that the Phase III, double-blind, placebo-controlled clinical trial for its leading drug candidate, KIT-302, successfully met the primary efficacy endpoint of the trial protocol as approved by the U.S. Food & Drug Administration (FDA).
A new study by UT Southwestern scientists indicates that an enzyme called protein phosphatase 2 (PP2A) appears to be a major driver of preeclampsia, a dangerous pregnancy complication characterized by the development of high blood pressure and excess protein in the urine.
Acupuncture does not appear to aid in stroke recovery, according to a new study published in CMAJ. This study, perhaps the most comprehensive to date as it includes trials published in English language and Asian journals, was a systematic review conducted by researchers in South Korea and the United Kingdom.
As the standoff continues between Capitol Hill Republicans and President Barack Obama over the government shutdown, the debt ceiling and GOP efforts to defund or delay the health law, Politico poses the question: what would be on the table if leaders did start talking.
› Verified 2 days ago